Isoprenoids as mediators of the biological effects of statins - Wikidata - awgldk - TriplyDB

Isoprenoids as mediators of the biological effects of statins

Isoprenoids as mediators of the biological effects of statins

http://www.wikidata.org/entity/Q34774535

about

Statins for the treatment of dementia Statins for the treatment of dementia Statins for the treatment of Alzheimer's disease and dementia Statins for the prevention of dementia The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins Timing of Administration: For Commonly-Prescribed Medicines in Australia Emerging therapies for the prevention of acute respiratory distress syndrome Protein prenylation and synaptic plasticity: implications for Alzheimer's disease Evaluation of the effect of genetic variation on the relationship between statins, cardiovascular disease and cancer Ongoing clinical trials of the pleiotropic effects of statins Statin therapy and autoimmune disease: from protein prenylation to immunomodulation Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility Hepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasis Mevalonate cascade regulation of airway mesenchymal cell autophagy and apoptosis: a dual role for p53 Brain cholesterol turnover required for geranylgeraniol production and learning in mice.Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells.Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease.Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair.Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice.Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study.Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer.Effects of lovastatin on breast cancer cells: a proteo-metabonomic study.Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis.Isoprenoid quantitation in human brain tissue: a validated HPLC-fluorescence detection method for endogenous farnesyl- (FPP) and geranylgeranylpyrophosphate (GGPP).Simvastatin treatment enhances NMDAR-mediated synaptic transmission by upregulating the surface distribution of the GluN2B subunit.Statins and myocardial remodelling: cell and molecular pathways.Cochrane review on 'Statins for the treatment of dementia'.The effect of rosuvastatin in a murine model of influenza A infection.The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells.Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.A genetic and pharmacological analysis of isoprenoid pathway by LC-MS/MS in fission yeast Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins.Role of cholesterol in the development and progression of breast cancer Statins decrease dendritic arborization in rat sympathetic neurons by blocking RhoA activation.Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease.Tumor-specific HMG-CoA reductase expression in primary premenopausal breast cancer predicts response to tamoxifen Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts

P2860

Q24194901-F3A7526F-A713-4239-9759-8C389F3D9A57 Q24236484-DB70EB30-BC19-4D58-99BA-45FFBC46A9E1 Q24240305-55496002-6EAE-43BD-8AE1-50F39B0DACA3 Q24241335-3B285121-C564-415F-B097-D6E591B2CAAA Q24681859-75C3DC91-4F53-43EA-A45B-977B8E33F740 Q24684244-7AE1927E-056B-4246-BE33-BEB56D06A6E4 Q26752357-1F85BAC8-4901-4DB2-8CD9-F3214B7F2A0F Q26822605-E8C7F498-DB80-40A3-896E-45B95F2E434D Q26858942-FB536F3B-0C51-4AA0-9C14-9B15F73670D8 Q27026358-822B5B34-5F00-4394-A6EC-9614B3C28688 Q28219321-A993AD95-C3C6-48AC-AD2F-3B093DCA65F0 Q28236647-184821E1-8C0C-4792-9AFE-C81F6CD2F589 Q28304661-7C98F709-3626-4763-9546-B26DA5A7E788 Q28384557-26B135FA-BE1C-4417-AC7F-05D9FF35AC44 Q28477034-B6345B49-BC71-480C-81A0-0B56396958A4 Q30477204-5A714940-A8A1-43D3-953F-1944B2C120BA Q33323649-27458D99-147A-4B93-8FF1-7DAD7A6C19EE Q33440583-41574931-569D-4470-A89C-3E782977A220 Q33548538-88C17034-B16C-4A5D-AB43-6FAB6883F127 Q33610240-DF0747A4-1B87-4BC1-AF54-3CAB77795001 Q33665597-34FF38F9-33C3-4C43-B497-B98C566B59BD Q33711829-60E56B06-14A9-454C-BAB3-5BBBF9E397B3 Q33864834-B93FDA05-63EB-478A-85B6-822044106CFE Q33889477-DFEFC484-3C47-4928-81B0-4E1DBE62BC02 Q34041112-A64B2CDF-94FF-4503-89F8-828365818A5F Q34071260-341D7CF4-637F-4C7D-B853-7906CDFA6541 Q34081527-DAFC6C03-F61C-42D5-A8F0-895D2AD00CC8 Q34196628-F3F36406-1DAC-48EF-90B3-150BE9B88953 Q34219516-64503872-73D6-4B66-8A2C-41F71986B2CF Q34247532-BE052397-2D36-45E5-963A-CA12A621DFB5 Q34282610-89790318-4C86-4250-98FF-0B9D804F2633 Q34378141-B49CFB97-2E43-48E2-8DEB-E39304DB2495 Q34473860-8FA033E4-4E7D-47BC-B7D3-CF79ED0873D9 Q34729472-BB146F10-9595-463C-858E-7F6F28C4DB65 Q34755686-543C5C77-622B-413B-8FEE-A9997DC69F3F Q34778613-16695B92-DCBE-41F0-8367-C9C0C67CA77C Q34988281-391E5110-2216-4A04-97B6-5CA69A6BAC21 Q35016920-5F0CC551-56C6-4BA0-8D96-4A82959C9071 Q35029556-1CA067B7-63C7-44C6-A2C5-79D7B8E304D0 Q35213717-7C1276FE-883B-4D4F-BD06-F08AC426F4B8

P2860

Isoprenoids as mediators of the biological effects of statins

http://www.wikidata.org/entity/Q34774535

description

2002 nî lūn-bûn

@nan

2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Isoprenoids as mediators of the biological effects of statins

@ast

Isoprenoids as mediators of the biological effects of statins

@en

Isoprenoids as mediators of the biological effects of statins

@nl

type

label

Isoprenoids as mediators of the biological effects of statins

@ast

Isoprenoids as mediators of the biological effects of statins

@en

Isoprenoids as mediators of the biological effects of statins

@nl

prefLabel

Isoprenoids as mediators of the biological effects of statins

@ast

Isoprenoids as mediators of the biological effects of statins

@en

Isoprenoids as mediators of the biological effects of statins

@nl

P1433

Q34774535-B1B22DDF-0EF7-45B3-A0D9-BBDD4D63FBE1

P1476

Q34774535-9F2439FC-6787-466A-B1B7-4D46D7DF225E

P2093

Q34774535-33FEB3BE-9EF4-48C1-9AB0-F9AAF58E1E8D

P2860

Q34774535-1499CBF6-C2FD-4D07-B8BC-6F0078B94A17

Q34774535-16FC747A-B8A1-4E9C-979E-8BB756A07A52

Q34774535-1A52E441-DFF0-4EBA-A9A6-BF67A443B659

Q34774535-28AC4029-8A91-4E37-B03F-D8F386F343B5

Q34774535-2A4B219E-1939-48AE-9DC0-15F6B1AB89F6

Q34774535-3613AD8F-A72A-4988-8CD0-EFC17C4A7A80

Q34774535-40BC0042-DEFD-4295-B6A0-6AF7BBD759CF

Q34774535-49523A66-0DFC-4728-93DB-4474E6F218C9

Q34774535-5FB2BAD6-9AF7-4E02-BA04-661AC02C8F95

Q34774535-6462C0F6-0D3F-4356-B965-6D44F358361A

P304

Q34774535-885E8C82-53B0-4158-B70A-062A1B8EA0E0

P31

Q34774535-A6ADD2BB-F23C-4217-8638-58465D43885D

P356

Q34774535-6F2CFF2D-10EE-4653-9FFE-C2257D7ED563

P407

Q34774535-9E1483A7-B08B-4DBA-B653-9F6A5EDC2C68

P433

Q34774535-722555FB-0AE4-49A1-9CB4-7297544F2E16

P478

Q34774535-3F85F4E4-211B-4C12-ACA7-8C5B77B6EE8B

P577

Q34774535-3D4E61B1-893B-4EB6-B3F6-1A1653E09D8D

P698

Q34774535-CEE7CB9A-E6C7-4480-B1A7-F30B8ADF76CA

P932

Q34774535-218418D2-0B7E-4843-AB71-0FB501C0E9D3

P356

P1433

Journal of Clinical Investigation

P1476

Isoprenoids as mediators of the biological effects of statins

@en

P2093

James K Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Structural mechanism for statin inhibition of HMG-CoA reductase

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells

Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy

Rho GTPases and signaling networks

Regulation of the mevalonate pathway

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.

P304

285-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0216421

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2002-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12163444

http://www.w3.org/2001/XMLSchema#string

P932

151100

http://www.w3.org/2001/XMLSchema#string